Overview

Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function

Status:
Completed
Trial end date:
2016-12-19
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the pharmacokinetics of ASP015K in patients with impaired renal function and subjects with normal renal function.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Peficitinib